EXHIBIT
32.2
CERTIFICATION
PURSUANT TO
18
U.S.C. § 1350
AS
ADOPTED PURSUANT
TOSECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report on Form 10-QSB of Novelos Therapeutics,
Inc., (the “Company”) for the quarter ended June 30, 2007, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), the
undersigned chief financial officer of the Company certifies, to his best
knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:
The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
|
/s/
George R. Vaughn
|
|
George
R. Vaughn
|
|
Chief
Financial Officer
|
Date:
August 10, 2007